Apoptosis induced by death receptors.

Area of Science:

• Cell Biology
• Immunology
• Molecular Biology

Background:

• Death receptors, part of the TNF receptor superfamily, possess intracellular death domains crucial for recruiting adapter proteins and initiating apoptosis.
• Ligand binding to death receptors, typically homotrimeric TNF family members, triggers downstream signaling cascades.
• Regulation of death receptor activation is complex, involving ligand form, decoy receptors, and intracellular modulators.

Purpose of the Study:

• To elucidate the mechanisms regulating death receptor-mediated apoptosis.
• To explore the roles of ligand status, decoy receptors, and intracellular proteins in modulating apoptosis signaling.
• To understand how these factors influence cytotoxic activity and downstream pathways like NF-kappa B.

Main Methods:

• Analysis of ligand-receptor interactions, including membrane-bound versus soluble forms (e.g., FasL, TRAIL).
• Investigation of decoy receptor function (e.g., TRAIL-R3) in inhibiting apoptosis.
• Examination of intracellular protein interactions (e.g., FLIP) with apoptotic pathway components.

Main Results:

• Soluble FasL (sFasL) binding to Fas is less cytotoxic than membrane-bound FasL, requiring aggregation of multiple Fas molecules for efficient apoptosis signaling.
• Decoy receptors like TRAIL-R3 can act as dominant-negative inhibitors of TRAIL-mediated apoptosis.
• FLIP, a Caspase-8 homolog, inhibits death receptor-induced apoptosis while potentially activating other pathways like NF-kappa B.

Conclusions:

• Death receptor activation and apoptosis are tightly regulated by multiple mechanisms.
• Ligand aggregation state and decoy receptors are critical for controlling cytotoxic signaling.
• Intracellular proteins offer further regulatory points, influencing both apoptosis and other cellular pathways.